Cannabis giant Canopy Growth’s international revenue shot up to 8.2 million Canadian dollars ($6.1 million) in the nine months ended Dec. 31, a nearly sixfold increase over the same period the year before, according to the company’s third quarter fiscal 2019 results.
International sales represented 5.6% of gross revenue in the quarter, more than doubling from 2.5% a year earlier. International sales, primarily to Germany, accounted for 16% of medical sales.
This post is from Marijuana Business Daily. We encourage our readers to continue reading the full article from the original source here.